45 Biggest Movers From Yesterday

Gainers

• Marin Software Incorporated MRIN shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
• Miromatrix Medical Inc. MIRO shares climbed 69.3% to settle at $15.24 after the company reported pricing of upsized initial public offering.
• Digital Brands Group, Inc. DBGI shares gained 31.1% to close at $5.36 after the company reported channel expansion into Amazon Marketplace.
• Confluent, Inc CFLT gained 25.1% to close at $45.02 after the company priced its IPO at $36 per share.
• FreightCar America, Inc. RAIL gained 24.6% to settle at $7.20 amid President Joe Biden declaring that the White House had struck an infrastructure deal with a bipartisan group of senators.
• Pieris Pharmaceuticals, Inc. PIRS climbed 23.5% to close at $4.37 after the company announced it received Orphan Drug Designation for cinrebafusp alfa for the treatment of gastric cancer.
• Celcuity Inc. CELC gained 20.8% to settle at $30.49 on below-average volume.
• GTT Communications, Inc. GTT jumped 20.2% to close at $2.98 after surging over 13% on Wednesday.
• Synchronoss Technologies, Inc. SNCR climbed 19.8% to close at $2.91.
• X Financial XYF climbed 19.7% to close at $11.56.
• DHI Group, Inc. DHX shares jumped 19.7% to close at $3.34 after the company announced it will add $12 million to its stock buyback, increasing the overall buyback to $20 million.
• Altisource Portfolio Solutions S.A. ASPS gained 19.7% to settle at $7.77.
• Gold Royalty Corp. GROY rose 17.8% to close at $6.66.
• Condor Hospitality Trust, Inc. CDOR gained 17.6% to close at $6.27.
• Processa Pharmaceuticals, Inc. PCSA rose 16.1% to settle at $8.74. Processa Pharmaceuticals recently entered into a licensing agreement with Ocuphire Pharma to in-license RX-3117.
• The Trade Desk, Inc. TTD jumped 16% to settle at $75.88 mid strength in advertising technology stocks after Google announced it is delaying the phase-out of third-party cookies on Chrome until 2023.
• Regional Health Properties, Inc. RHE gained 15.6% to close at $14.48.
• Live Ventures Incorporated LIVE jumped 15.6% to settle at $69.78.
• SEMrush Holdings, Inc. SEMR surged 15.5% to close at $23.34.
• Arcus Biosciences, Inc. RCUS shares surged 15.5% to close at $27.02 after the company disclosed data from the first interim analysis of the three-arm randomized Phase 2 ARC-7 study.
• Moxian, Inc. MOXC rose 14.7% to close at $23.04 after jumping 22% on Wednesday.
• Kaleido Biosciences, Inc. KLDO climbed 13.5% to close at $7.93 on above-average volume.
• Grove, Inc. GRVI rose 12% to settle at $5.60 after the company priced its IPO at $5 per share.
• Sprinklr, Inc. CXM shares gained 11.6% to close at $19.64. Sprinklr shares gained 10% on Wednesday after the company priced its IPO at $16 per share.
• Sierra Wireless, Inc. SWIR gained 11.6% to settle at $18.63. Craig-Hallum initiated coverage on Sierra Wireless with a Buy rating and announced a price target of $22.
• India Globalization Capital, Inc. IGC gained 11.5% to close at $1.65. IGC said it has completed the final Cohort of its Phase 1 Clinical trial on Alzheimer’s patients.
• Uxin Limited UXIN gained 9.9% to settle at $4.11 after gaining over 7% on Wednesday.
• Orphazyme A/S ORPH rose 9.5% to close at $8.15. Orphazyme, which recently faced a regulatory setback, said the Goldman Sachs Group briefly increased its stake in Orphazyme above 5%.
• Lightning eMotors, Inc. ZEV gained 9.2% to close at $8.33. Oppenheimer initiated coverage on Lightning eMotors with an Outperform rating and announced a price target of $15.
• Compugen Ltd. CGEN rose 8.9% to close at $8.47. The company recently announced updated data from its Phase 1 dose-escalation and expansion study of COM701 as a monotherapy and in a dose-escalation combination study with Bristol-Myers Squibb’s Opdivo (nivolumab).
• Eli Lilly and Company LLY climbed 7.3% to close at $232.97 after the company said its Donanemab received U.S. FDA's Breakthrough Therapy designation for the treatment of Alzheimer's disease.
• Tower Semiconductor Ltd. TSEM gained 6.2% to close at $29.05 after the company, and STMicroelectronics, announced an agreement by which ST will welcome Tower to its Agrate R3 300mm fab under construction on its Agrate Brianza site in Italy.
• Aravive, Inc. ARAV rose 5.3% to close at $5.60 after the company announced initial results from the Phase 1b portion of its Phase 1b/2 study of AVB-500. The company said AVB-500 was well tolerated and they plan to expand dosing to 3 additional patients.

Check out these big penny stock gainers and losers

Losers

• Portage Biotech Inc. PRTG shares dipped 25.4% to close at $25.95 on Thursday after the company reported pricing of public offering of 1 million ordinary shares at $23 per share.
• Rite Aid Corporation RAD fell 14.5% to close at $17.46 after the company reported weaker-than-expected Q1 sales.
• Adial Pharmaceuticals, Inc. ADIL shares declined 14.3% to close at $2.52 after dropping 6% on Wednesday. The company recently announced plans to enter genetic testing market following allowance of U.S. patent for genetic diagnostic test.
• Aesthetic Medical International Holdings Group Limited AIH dipped 12.9% to settle at $7.91 after the company reported Q1 earnings results.
• Talaris Therapeutics, Inc. TALS fell 10.9% to settle at $13.69. The company recently reported a wider quarterly loss.
• Vinco Ventures, Inc. BBIG fell 10.7% to close at $4.26 after the company announced it will spin out its Emmersive Entertainment unit.
• 4D Molecular Therapeutics, Inc. FDMT fell 10.4% to close at $22.20. 4D Molecular Therapeutics an update on their rare disease ophthalmology product candidate portfolio, including initial clinical safety and tolerability data for 4D-110 for choroideremia and 4D-125 for XLRP, and termination of Roche collaboration and license agreement.
• Clearside Biomedical, Inc. CLSD tumbled 10% to settle at $4.84.
• DouYu International Holdings Limited DOYU dropped 9.8% to close at $7.11.
• Oasis Midstream Partners LP OMP fell 9.3% to close at $27.93. Oasis Midstream Partners priced its public offering of 3.623 million common units after the closing bell on Thursday.
• Terns Pharmaceuticals, Inc. TERN dipped 9.2% to settle at $13.39. Terns reported initiation of patient dosing in AVIATION Phase 1b NASH clinical trial of VAP-1 Inhibitor TERN-201 after the closing bell.
• Talos Energy Inc. TALO shares fell 6.4% to close at $17.45 after the company reported the pricing of secondary public offering of common stock.